Have Scientists Discovered the Maximum Human Lifespan? The Telomere Puzzle and the Search for Immortality

0

For thousands of years humanity has searched for the secret to living longer. Ancient civilisations imagined magical fountains of youth, while modern science has replaced mythology with genetics, stem cells and molecular biology. Today, longevity research has become one of the fastest-growing areas of medicine, attracting billions of pounds of investment from governments, pharmaceutical companies and technology entrepreneurs. Yet despite remarkable progress, one question continues to fascinate scientists and the public alike: is there a maximum human lifespan?

The oldest verified person in history, Jeanne Calment of France, lived to 122 years and 164 days before dying in 1997. Despite enormous advances in healthcare, nutrition and sanitation, nobody has convincingly surpassed her record. This has led many researchers to ask whether biology itself imposes an upper limit that even future medical technology may struggle to overcome.

Recent research suggests that while humans may eventually live significantly longer than they do today, true biological immortality remains unlikely. Rather than identifying a single “ageing clock”, scientists increasingly believe that ageing results from multiple interacting biological processes that gradually overwhelm the body’s ability to repair itself. One of the best-known of these processes involves structures called telomeres.

Telomeres are protective DNA sequences located at the ends of chromosomes. They function rather like the plastic caps found on the ends of shoelaces, preventing chromosomes from fraying or becoming damaged during cell division. Every time most human cells divide, a small section of the telomere is lost. Eventually these protective caps become so short that the cell can no longer divide safely, entering a dormant state known as cellular senescence or undergoing programmed cell death (Blackburn, Epel and Lin, 2015).

For many years, telomeres were considered the biological clock of ageing. The logic appeared convincing. Older individuals generally possess shorter telomeres than younger people, while diseases associated with premature ageing frequently involve accelerated telomere shortening. The hypothesis suggested that extending telomeres might dramatically increase human lifespan.

Unfortunately, biology is rarely that straightforward.

The body possesses an enzyme known as telomerase, capable of rebuilding and extending telomeres. In stem cells and reproductive cells, telomerase allows continuous cell division throughout life. However, this same enzyme presents one of medicine’s greatest challenges. Approximately 85–90% of human cancers reactivate telomerase, allowing malignant cells to divide almost indefinitely (Shay and Wright, 2019). In other words, the same mechanism that could potentially extend lifespan also enables cancer cells to become effectively immortal.

This creates one of the greatest paradoxes in longevity research. Scientists cannot simply activate telomerase throughout the body because doing so could substantially increase cancer risk. Instead, researchers are attempting to understand how telomere maintenance can be carefully regulated without encouraging uncontrolled cell growth.

During the past decade, researchers have increasingly recognised that telomeres represent only one part of a much larger ageing process. In 2023, scientists updated the influential “Hallmarks of Ageing” framework to include twelve interconnected biological mechanisms contributing to ageing, including genomic instability, telomere attrition, epigenetic alterations, mitochondrial dysfunction, chronic inflammation and impaired cellular recycling. These hallmarks interact continuously throughout life, suggesting that no single therapy is likely to eliminate ageing altogether.

Perhaps the most fascinating development arrived in 2026, when researchers from the Skolkovo Institute of Science and Technology attempted to answer a remarkable question. Instead of studying current human ageing, they asked what would happen if future medicine completely eliminated every known hallmark of ageing except one: the gradual accumulation of unavoidable DNA mutations.

Every cell in the human body experiences random mutations throughout life. Most are harmless, while many are repaired by sophisticated cellular repair mechanisms. However, some mutations inevitably remain. Over decades these small genetic errors accumulate, particularly in tissues whose cells divide very rarely, such as neurons within the brain and muscle cells within the heart.

Using advanced mathematical modelling, the researchers estimated the consequences of these unavoidable mutations if every other ageing mechanism could somehow be eliminated. Surprisingly, they concluded that the median theoretical maximum human lifespan would still lie somewhere between 146 and 194 years.

Although this estimate is dramatically higher than current human life expectancy, it falls well short of immortality.

The study also demonstrated an important difference between organs. Tissues such as the liver and skin constantly replace damaged cells, effectively removing many accumulated mutations. In contrast, brain neurons and heart muscle cells persist for decades with little natural replacement. These long-lived cells gradually accumulate irreversible genetic damage, eventually becoming the biological bottleneck that limits lifespan.

This finding shifts the conversation away from telomeres alone. Instead, scientists increasingly view ageing as the cumulative result of multiple overlapping forms of damage occurring simultaneously. DNA mutations, mitochondrial dysfunction, protein misfolding, chronic inflammation, epigenetic drift and telomere shortening all contribute to declining biological function. Extending telomeres alone cannot prevent these other processes from continuing.

Consequently, many longevity researchers are abandoning the search for a single miracle treatment. Instead, they are developing combinations of therapies targeting multiple ageing mechanisms simultaneously. Senolytic drugs attempt to remove ageing cells from the body. Partial cellular reprogramming seeks to restore youthful patterns of gene expression. Gene-editing technologies aim to repair harmful mutations, while artificial intelligence is increasingly accelerating the discovery of entirely new anti-ageing medicines by analysing enormous biological datasets.

Equally important is the distinction between lifespan and healthspan. Most scientists are less interested in simply increasing the number of years people remain alive than ensuring those years are spent in good physical and cognitive health. Extending healthy adulthood by twenty years may prove far more valuable than extending frailty for several decades.

The search for longevity also raises profound philosophical questions. Even if medicine eventually allows humans to routinely reach 150 years of age, death may still remain inevitable because biology itself imposes unavoidable physical constraints. This possibility has encouraged growing interest in complementary ideas such as digital preservation, artificial intelligence and robotic embodiment. While these technologies would not preserve biological consciousness, they may eventually allow aspects of a person’s knowledge, personality and memories to continue long after physical death.

For now, however, biology continues to set the rules. Telomeres remain one of the most important pieces of the ageing puzzle, but they are no longer viewed as the entire explanation. Recent research suggests that ageing resembles a complex network rather than a single countdown timer. The future of longevity research therefore lies not in defeating one biological process, but in understanding—and perhaps eventually coordinating—the repair of many interacting systems simultaneously.

If the latest research proves correct, humanity may one day double today’s average lifespan. Yet the dream of biological immortality remains beyond our grasp, reminding us that even the most advanced science must ultimately contend with the remarkable complexity of life itself.

References

Blackburn, E.H., Epel, E.S. and Lin, J. (2015) ‘Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection’, Science, 350(6265), pp. 1193–1198.

López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2023) ‘Hallmarks of aging: An expanding universe’, Cell, 186(2), pp. 243–278.

Efimov, E., Fedotov, V., Malaev, L., Khrameeva, E.E., Kriukov, D. et al. (2026) ‘Somatic mutations impose an entropic upper bound on human lifespan’, npj Aging. Available at: https://doi.org/10.1038/s41514-026-00421-6 (Accessed: 27 July 2026).

Gai, K. et al. (2026) ‘Genetic and molecular factors underlying human longevity and epigenetic aging’, npj Aging. Available at: https://doi.org/10.1038/s41514-026-00384-8 (Accessed: 27 July 2026).

Shay, J.W. and Wright, W.E. (2019) ‘Telomeres and telomerase: Three decades of progress’, Nature Reviews Genetics, 20(5), pp. 299–309.